U.S. market Closed. Opens in 5 hours

TNYA | Tenaya Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue8.69M8.71M4.03M2.48M1.99M
Gross Profit-8.69M-8.71M-4.03M-2.48M-1.99M
Operating Expenses122.51M125.62M72.81M38.91M27.71M
Selling, General & Admin24.47M31.08M18.41M7.81M4.56M
Research & Development98.04M94.54M54.39M31.10M23.15M
Other Operating ExpensesN/A2.00K-23.00K430.00K1.03M
Operating Income-131.19M-125.62M-72.81M-38.91M-27.71M
Other Expenses / Income7.11M1.96M85.00K517.00K1.48M
Before Tax Income-124.08M-123.67M-72.72M-38.40M-26.23M
Income Tax Expenses8.52M-1.96K-3.07M-87.00K-453.00K
Net Income-124.08M-123.66M-69.65M-38.31M-25.78M
Interest ExpensesN/A-1.96KN/AN/AN/A
Basic Shares Outstanding73.79M44.82M41.29M41.12M41.12M
Diluted Shares Outstanding73.79M44.82M41.29M41.12M41.12M
EBITDA-122.51M-125.62M-72.81M-36.43M-25.72M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-115.56M-123.67M-72.72M-38.40M-26.23M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙